Target intelligence / Profile preview

Envelope glycoprotein gp120 with V2 loop deletion (gp120 ΔV2 (or gp120 V2-deleted))

Target
gp120 ΔV2 (or gp120 V2-deleted)
Molecular classification
Viral envelope protein, Glycoprotein, Receptor-binding protein
01

Overview

Envelope glycoprotein gp120 with V2 loop deletion is a mutant form of the HIV-1 envelope glycoprotein in which the V2 loop, a highly variable and immunologically important region, has been removed. The gp120 protein is part of the Env trimer complex (along with gp41), mediates the initial binding to the host cell CD4 receptor and subsequently to a chemokine coreceptor (CCR5 or CXCR4), enabling viral entry. The V2 loop in wild-type gp120 plays multiple roles: it contributes to the stabilization of the trimer, masks neutralizing epitopes, participates in receptor and coreceptor binding, and serves as a major site targeted by broadly neutralizing antibodies. Deletion of the V2 loop alters the exposure of other regions (especially the V3 loop and CD4-binding site), dramatically increases sensitivity to neutralizing antibodies, often abrogates the proper folding, surface expression, and function of the envelope glycoprotein, and impairs viral infectivity. However, ΔV2 gp120 is a useful tool in virology and immunogen design to study epitope exposure and neutralization mechanisms.

Other names
gp120 V2-deletedHIV-1 envelope glycoprotein gp120 ΔV2Env gp120 V2 deletion mutant
02

Mechanism of action

For neutralizing antibodies and entry inhibitors: Blockade of gp120 binding to CD4 and/or CCR5/CXCR4, preventing viral entry into host cells

03

Biological functions

Mediates viral entry into host cells (via binding CD4 and coreceptor)Determines tropism and host cell specificityEngages in immune evasion (in wild-type; V2 loop is important for masking neutralizing epitopes; deletion affects this function)Trimer formation and stabilization (in intact Env; V2 important for trimer stability)
04

Disease associations

Infection (HIV-1/AIDS pathology)Immune evasion (in wild-type gp120)Target for vaccine and immunogen design
05

Safety considerations

For use as immunogen (vaccine candidate): Potential loss of protective antibody responses targeting V2 epitopes; possible conformational changes exposing cryptic epitopes that could be less protective or alter immune recognitionFor therapeutic targeting: Modified antigenicity; could drive escape variants if used in a therapeutic context
06

Interacting drugs

Broadly neutralizing antibodies (e.g., VRC01, PG9, PG16, CH01, PGT145, etc.; note: some specifically target wild-type V2 epitopes, so may lose binding to ΔV2 mutants)

1 more in the full profile.

07

Biomarkers

Anti-gp120 antibody titers (used in HIV vaccine trials; specific response depends on antigen form; anti-V1V2 IgG is a correlate of reduced risk in RV144 vaccine trial, but not present in this deleted mutant)gp120 detection (for viral load, less relevant for this engineered form)

Beyond the preview

Go deeper on Envelope glycoprotein gp120 with V2 loop deletion (gp120 ΔV2 (or gp120 V2-deleted)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Envelope glycoprotein gp120 with V2 loop deletion (gp120 ΔV2 (or gp120 V2-deleted)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call